Samura, B. “Influence of Atorvastatin Therapy on Biological Markers and Cardiovascular Risk in Patients With Chronic Lymphocytic Leukemia in Remission”. Zaporozhye Medical Journal, no. 1, Feb. 2019, doi:10.14739/2310-1210.2019.1.155793.